- Agricultural-Biological Sciences
- Arts & Humanities
- Biochemistry, Genetics, Molecular Biology
- Business Management Accounting
- Chemical Engineering
- Chemistry
- Computer Science
- Decision Sciences
- Earth & Planetary Sciences
- Economics, Econometrics, Finance
- Energy
- Engineering
- Environmental Science
- Immunology & Microbiology
- Materials Science
- Mathematics
- Medicine
- Neuroscience
- Nursing
- Pharmacology. Toxicology. Pharmaceutics.
- Physics and Astronomy
- Psychology
- Social Sciences
- Veterinary
- Dentistry
- Health Professions
- Sports Science
- Military & Naval Sciences
- Multidisciplinary
- Call for Papers
Alzheimer's and Dementia: Translational Research and Clinical Interventions
Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI) is a peer-reviewed, open access,journal from the Alzheimer’s Association®. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies, validating putative therapies for aging-related chronic brain conditions that affect cognition, motor functions, and other behavioral or clinical symptoms associated with all forms dementia and Alzheimer’s disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge: specifically, to translate what is learned at the bench into bedside applications.
The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather, an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development.
For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions, TRCI will consider only original contributions that include feature length research articles, systematic reviews, meta-analyses, brief reports, narrative reviews, commentaries, letters, perspectives, and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimer’s disease.
The journal will publish on topics related to medicine, geriatrics, neuroscience, neurophysiology, neurology, psychiatry, clinical psychology, bioinformatics, pharmaco-genetics, regulatory issues, health economics, pharmacoeconomics, and public health policy as these apply to preclinical and clinical research on therapeutics.